Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
ABMD Abiomed, Inc. daily Stock Chart
ABMD [NASD]
Abiomed, Inc.
Healthcare | Medical Appliances & Equipment | USA
statements
IndexS&P 500 P/E27.24 EPS (ttm)5.33 Insider Own0.70% Shs Outstand46.28M Perf Week11.29%
Market Cap6.72B Forward P/E32.03 EPS next Y4.54 Insider Trans-1.22% Shs Float44.15M Perf Month-5.67%
Income245.20M PEG1.14 EPS next Q0.99 Inst Own- Short Float9.07% Perf Quarter-15.07%
Sales841.30M P/S7.99 EPS this Y92.60% Inst Trans6.96% Short Ratio4.32 Perf Half Y-18.24%
Book/sh23.19 P/B6.26 EPS next Y-3.12% ROA21.80% Target Price199.00 Perf Year-48.84%
Cash/sh9.24 P/C15.72 EPS next 5Y24.00% ROE24.70% 52W Range119.01 - 293.44 Perf YTD-14.86%
Dividend- P/FCF26.19 EPS past 5Y99.70% ROI23.50% 52W High-50.50% Beta0.59
Dividend %- Quick Ratio4.30 Sales past 5Y33.20% Gross Margin82.60% 52W Low22.04% ATR10.37
Employees1371 Current Ratio5.00 Sales Q/Q10.50% Oper. Margin30.50% RSI (14)44.26 Volatility8.00% 7.54%
OptionableYes Debt/Eq0.00 EPS Q/Q55.80% Profit Margin29.10% Rel Volume0.54 Prev Close149.17
ShortableYes LT Debt/Eq0.00 EarningsMay 07 BMO Payout0.00% Avg Volume927.24K Price145.24
Recom2.10 SMA20-1.52% SMA50-12.14% SMA200-25.28% Volume500,887 Change-2.63%
Feb-12-20Downgrade Morgan Stanley Equal-Weight → Underweight $165
Feb-06-20Resumed BTIG Research Neutral
Oct-29-19Downgrade Raymond James Outperform → Mkt Perform
Aug-02-19Downgrade Morgan Stanley Overweight → Equal-Weight $325 → $215
Aug-02-19Downgrade Guggenheim Buy → Neutral
Aug-01-19Downgrade BTIG Research Buy → Neutral
Nov-07-18Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-02-18Upgrade BTIG Research Neutral → Buy
Jun-22-18Reiterated Piper Jaffray Overweight $360 → $480
Apr-04-18Initiated Goldman Buy $332
Jan-19-18Reiterated Leerink Partners Outperform $200 → $265
Oct-16-17Downgrade BTIG Research Buy → Neutral
Sep-29-17Initiated SunTrust Buy $195
Jun-08-17Resumed William Blair Outperform
Apr-06-17Upgrade Piper Jaffray Neutral → Overweight
Dec-07-16Initiated Guggenheim Buy
Oct-30-15Upgrade Raymond James Mkt Perform → Outperform
Aug-18-15Initiated Sterne Agee CRT Buy $130
Aug-12-15Reiterated The Benchmark Company Buy $96 → $129
Aug-05-15Reiterated Northland Capital Market Perform $60 → $80
Mar-26-20 11:40AM  IART vs. ABMD: Which Stock Is the Better Value Option? Zacks
Mar-25-20 07:05AM  Abiomeds Response to the COVID-19 Pandemic Business Wire
Mar-22-20 11:05PM  Hedge Funds Have Never Been This Bullish On ABIOMED, Inc. (ABMD) Insider Monkey
Mar-19-20 07:11PM  Finding Companies That Can Survive Hard Times GuruFocus.com
Mar-10-20 11:40AM  IART vs. ABMD: Which Stock Should Value Investors Buy Now? Zacks +5.35%
Mar-09-20 10:13AM  Neovasc (NVCN) Releases Update on Reducer and Tiara Products Zacks
07:23AM  Is Abiomed, Inc.'s (NASDAQ:ABMD) ROE Of 23% Impressive? Simply Wall St.
Mar-07-20 11:30AM  Abiomed (ABMD) Down 19.9% Since Last Earnings Report: Can It Rebound? Zacks
Mar-05-20 10:00AM  These Medical Stocks Are Outperforming 95% Of All Stocks Here's Why Investor's Business Daily
Mar-04-20 07:05AM  Study of 21,848 High-Risk PCI Patients Demonstrates Lower Risk of Death and Complications in Patients who Receive PVADs (Impella) Business Wire
Feb-24-20 08:52AM  Wall Street has slashed these S&P 500 companies estimates by as much as 70% MarketWatch
Feb-12-20 02:35AM  Edited Transcript of ABMD earnings conference call or presentation 6-Feb-20 1:00pm GMT Thomson Reuters StreetEvents -5.05%
Feb-10-20 11:47AM  Wall Street Opens Higher Monday GuruFocus.com -6.86%
05:30AM  Abiomed, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year Simply Wall St.
Feb-07-20 04:01PM  US Stock Market Red on Friday GuruFocus.com
Feb-06-20 09:30AM  ABIOMED (ABMD) Earnings Beat Estimates in Q3, Revenues Miss Zacks
07:00AM  Abiomed Announces Q3 FY 2020 Revenue of $222 Million and 31.7% Operating Margin Business Wire
06:00AM  ABIOMED, Inc. to Host Earnings Call ACCESSWIRE
Feb-05-20 08:52AM  Medical Products Stock Feb 6 Earnings Roster: BDX, CAH & More Zacks
Jan-31-20 10:44AM  ABIOMED (ABMD) to Report Q3 Earnings: What's in the Offing? Zacks
Jan-30-20 02:57PM  6 Stocks Killing Gurus' Returns GuruFocus.com
Jan-27-20 03:16PM  Looking Back at 2019 GuruFocus.com
Jan-25-20 08:02AM  Is Abiomed, Inc.'s (NASDAQ:ABMD) CEO Pay Justified? Simply Wall St.
Jan-21-20 04:18PM  Global Markets Turn Red Tuesday GuruFocus.com
Jan-18-20 12:46PM  Extreme greed in the stock market is producing a bad setup as earnings season starts MarketWatch
Jan-14-20 07:22AM  ABIOMED (ABMD) Announces Preliminary Q3 Results, Slashes View Zacks
Jan-13-20 12:50PM  The Dow Is Up 80 Points Because There Is Little Holding It Back Barrons.com -11.09%
10:17AM  All 4 of Analysts' Favorite Stocks Fell Last Year GuruFocus.com
07:00AM  Abiomed Announces Preliminary Q3 FY 2020 Revenue of $222 Million, up 10% Over Prior Year Business Wire
06:29AM  Abiomed Sinks After Heart Pump Maker Cuts Full-Year Revenue Forecast TheStreet.com
Jan-03-20 12:10PM  Why Abiomed (ABMD) Could Beat Earnings Estimates Again Zacks
Jan-02-20 01:05PM  Top 5 Best-Performing Stocks of the Past Decade GuruFocus.com
Dec-30-19 08:24AM  5 Best-Performing Technology Stocks of a Decade Zacks
07:00AM  Abiomed to Present at the 38th Annual J.P. Morgan Healthcare Conference Business Wire
05:12AM  Should You Like Abiomed, Inc.s (NASDAQ:ABMD) High Return On Capital Employed? Simply Wall St.
Dec-28-19 04:22PM  These are the 20 best-performing stocks of the past decade, and some of them will surprise you MarketWatch
Dec-24-19 01:14PM  Stock market news: December 24, 2019 Yahoo Finance
Dec-21-19 04:51PM  These 10 S&P 500 stocks were lousy in 2019, but they could return 40% or more in 2020 MarketWatch
Dec-20-19 04:29PM  Top Stocks Of The 2010s Zacks
Dec-19-19 06:50PM  Top Stocks Of The Decade Zacks
Dec-18-19 12:56PM  6 Underperforming Guru Stocks GuruFocus.com
Dec-16-19 03:02PM  10 Stocks to Buy That Lost 8%-Plus in the Past Month InvestorPlace
12:25PM  The Dow Is Up 175 Points Because the Trade War News Is Sinking In Barrons.com
08:05AM  First Patient Enrolls in STEMI DTU Randomized Controlled FDA Trial; Study Aims to Further Demonstrate Impellas Safety and Effectiveness Business Wire
07:58AM  Large Randomized Controlled Trial Aims to Curb Rising Epidemic of Heart Failure Business Wire
Dec-12-19 07:06AM  Abiomed (ABMD) Alert: Johnson Fistel Launches Investigation into Abiomed, Inc.; Investors Encouraged to Contact Firm PR Newswire
Dec-11-19 04:03PM  Hedge Funds Are Selling ABIOMED, Inc. (ABMD) Insider Monkey
Dec-04-19 09:11AM  The stock market's biggest winners and losers of the past decade Yahoo Finance
05:00AM  Money in Medicine: These drug and device companies paid the most to D.C. doctors in 2018 American City Business Journals
Dec-03-19 04:45PM  4 Big Name Stocks To Weigh Selling Now Before Losses Widen Investopedia
11:22AM  Cramer Weighs In On Biogen, Caterpillar And More Benzinga
05:18AM  Did You Miss Abiomed's (NASDAQ:ABMD) Whopping 426% Share Price Gain? Simply Wall St.
Nov-29-19 06:26PM  The S&P 500 Notches Its 26th Record This Year Before Falling Back Barrons.com
Nov-28-19 07:00AM  The 3 Worst-Performing Health Care Stocks of 2019 So Far Barrons.com
Nov-27-19 03:08PM  10 Best Stocks of the Past 10 Years Kiplinger
07:00AM  Abiomed to Present at the 31st Annual Piper Jaffray Healthcare Conference TEST Business Wire Releases
Nov-19-19 01:11PM  Abiomed Medical Office Completes Review of Observational Analysis of Impella Presented at AHA Business Wire
Nov-18-19 01:51PM  Stocks Are Going Nowhere as Hope for a China Trade Deal Wavers Barrons.com -20.22%
07:01AM  [video]Abiomed Shares Take Beating After Studies Question Heart Pump TheStreet.com
Nov-14-19 09:59AM  Clinical Review Demonstrates Cost-Effectiveness of Impella in High-Risk PCI and Cardiogenic Shock Business Wire
Nov-12-19 07:05AM  Lawsuit for Investors in Abiomed, Inc. (NASDAQ: ABMD) shares announced by Shareholders Foundation ACCESSWIRE
Nov-11-19 06:40PM  Edited Transcript of ABMD earnings conference call or presentation 31-Oct-19 12:00pm GMT Thomson Reuters StreetEvents
Nov-08-19 02:18PM  3 Former Growth Stocks to Consider Buying Again InvestorPlace
Nov-05-19 06:20AM  What Is Abiomed's (NASDAQ:ABMD) P/E Ratio After Its Share Price Rocketed? Simply Wall St.
Oct-31-19 06:58PM  US Stocks Tumble Thursday GuruFocus.com +14.20%
02:25PM  Impressive Near-Term Outlook for Medical Instruments Industry Zacks
10:02AM  Abiomed Shares Climb After Medical-Tech Provider Reiterates Earnings Guidance TheStreet.com
09:01AM  ABIOMED (ABMD) Earnings Beat, Revenues Miss Estimates in Q2 Zacks
08:15AM  Abiomed (ABMD) Q2 Earnings Top Estimates Zacks
07:02AM  First U.S. Patients Treated with Impella 5.5 with SmartAssist, a Minimally Invasive, Forward Flow Heart Pump Business Wire
07:00AM  Abiomed Announces Q2 FY 2020 Revenue of $205 Million and 29.4% Operating Margin Business Wire
06:00AM  ABIOMED, Inc. to Host Earnings Call ACCESSWIRE
Oct-30-19 12:44PM  Medical Instruments' Oct 31 Earnings Roster: IDXX, ABMD & More Zacks
Oct-29-19 01:00PM  12 Stocks With The Highest Returns On Assets Benzinga
Oct-26-19 09:15AM  CORRECTING and REPLACING CAPTION FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival Business Wire
Oct-25-19 10:25AM  ABIOMED (ABMD) to Report Q2 Earnings: What's in the Offing? Zacks
09:55AM  CORRECTING and REPLACING GRAPHIC FDA Post Approval Study Demonstrates Timely Identification of Right Heart Failure and Early Use of Impella RP Leads to Higher Survival Business Wire
Oct-24-19 10:32AM  Abiomed (ABMD) Earnings Expected to Grow: Should You Buy? Zacks
Oct-23-19 03:26PM  16 Stocks With The Highest Long-Term Sales Growth Rate Benzinga
Oct-22-19 06:01AM  Do You Know What Abiomed, Inc.'s (NASDAQ:ABMD) P/E Ratio Means? Simply Wall St.
Oct-21-19 11:28AM  Cramer Advises His Viewers On Beyond Meat, Texas Instruments And More Benzinga
Oct-20-19 03:18PM  Hedge Funds Arent Crazy About ABIOMED, Inc. (ABMD) Anymore Insider Monkey
Oct-14-19 12:08PM  7 Under-The-Radar Growth Stocks That Could Benefit New Investors InvestorPlace
Oct-11-19 03:20PM  Wall Street Rallies Friday GuruFocus.com
Oct-10-19 03:55PM  Abiomed Second Quarter Fiscal 2020 Earnings and Conference Call Notification Business Wire
Oct-08-19 10:04AM  AngioDynamics Boosts VIT Product Portfolio With New Buyout Zacks
Oct-07-19 12:20PM  CLASS ACTION UPDATE for ABMD, WTRH and MYGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders ACCESSWIRE
10:40AM  MONDAY DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Abiomed, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
10:08AM  FINAL DEADLINE ALERT - Abiomed, Inc. (ABMD) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Deadline: October 7, 2019 ACCESSWIRE
09:40AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABMD, EVH, WTRH and MYGN GlobeNewswire
08:00AM  Abiomed Announces 1,000th Patient Treated with Impella in Japan Business Wire
Oct-06-19 02:30PM  ROSEN, A LEADING LAW FIRM, Reminds Abiomed, Inc. Investors of Important October 7th Deadline in Securities Class Action; Encourages Investors with Losses in Excess of $100K to Contact the Firm ABMD GlobeNewswire
10:46AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABMD, CVS and CADE ACCESSWIRE
Oct-04-19 08:35PM  FINAL DEADLINE MONDAY: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Abiomed, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
03:50PM  SHAREHOLDER ALERT: CURLF ABMD OSTK: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
03:00PM  SHAREHOLDER ALERT - Abiomed, Inc. (ABMD) - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action and Lead Deadline: October 7, 2019 GlobeNewswire
10:15AM  The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of ABMD, EVH and VAL ACCESSWIRE
10:05AM  ABMD, IFF & GVA - Class Action Update - Bronstein, Gewirtz & Grossman, LLC ACCESSWIRE
09:02AM  ABIOMED DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In ABIOMED, Inc. To Contact The Firm Newsfile
Oct-03-19 12:30PM  SHAREHOLDER ALERT: ABMD FTCH OLLI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines ACCESSWIRE
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; and Impella RP, a percutaneous catheter-based axial flow pump. In addition, the company engages in the development of Impella 5.5 and Impella BTR that are percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
THOMAS PAULDirectorMar 02Sale151.782,000303,5618,920Mar 04 04:23 PM
THOMAS PAULDirectorFeb 10Sale181.132,000362,25010,920Feb 12 05:14 PM
Weber David MChief Operating OfficerAug 05Option Exercise21.554,17589,971132,913Aug 07 04:15 PM
Weber David MChief Operating OfficerAug 05Sale206.268,0951,669,693124,818Aug 07 04:15 PM
SUTTER MARTIN PDirectorMay 08Option Exercise7.6712,00092,040192,550May 10 04:10 PM
SUTTER MARTIN PDirectorMay 08Sale259.974,6641,212,494187,886May 10 04:10 PM
open in yahoo | open in reuters | open in google